Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.000440528634361146 -0.010511013215859 -0.00704845814977959
Stock impact report

Cancer Research Highlights: Signs Point To Success For Puma's Foray Into Metastatic Breast Cancer [Seeking Alpha]

Puma Biotechnology Inc (PBYI) 
Last puma biotechnology inc earnings: 2/20 04:07 pm Check Earnings Report
US:NYSE Investor Relations: pumabiotechnology.com/ir.html
Company Research Source: Seeking Alpha
Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. Puma Biotechnology ( PBYI ) has fashioned their commercial development around a single HER2-directed tyrosine kinase inhibitor: neratinib. As you may know, HER2 is a major target of interest in a relatively common form of breast cancer. Therapy in this area has been dominated by the anti-HER2 antibody trastuzumab (branded Herceptin by Roche ( OTCQX:RHHBF )), which transformed the prognosis of HER2-positive disease from rapidly fatal to manageable for a long time. Still, patients with metastatic breast cancer often end up progressing on the HER2-directed antibodies, which has driven a good bit of research over the past 10 years. One approach to trying to overcome resistance is with small-molecule inhibitors like lapatin Show less Read more
Impact Snapshot
Event Time:
PBYI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
PBYI alerts

from News Quantified
Opt-in for
PBYI alerts

from News Quantified